Randomized trial of Lipid lowering Therapy for Endothelial Function;Statin Monotherapy Compared with Statin/Ezetimibe or Statin/Eicosapentaenoic Acid Combination Therapy

Trial Profile

Randomized trial of Lipid lowering Therapy for Endothelial Function;Statin Monotherapy Compared with Statin/Ezetimibe or Statin/Eicosapentaenoic Acid Combination Therapy

Suspended
Phase of Trial: Phase IV

Latest Information Update: 10 Jun 2013

At a glance

  • Drugs Atorvastatin (Primary) ; Atorvastatin/ezetimibe (Primary) ; Eicosapentaenoic acid (Primary)
  • Indications Hyperlipidaemia; Ischaemic heart disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Jun 2013 Status changed from recruiting to suspended as reported by University Hospital Medical Information Network - Japan.
    • 05 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top